Related Experiment Videos
Current comprehensive therapy of habitual abortion
1Department of Obstetrics and Gynecology, School of Medicine, Keio University, Japan.
Annals of the New York Academy of Sciences
|January 1, 1991
Summary
Recurrent pregnancy loss can be effectively treated with early diagnosis and targeted interventions. Surgical correction of uterine abnormalities and immunotherapy for antiphospholipid syndrome significantly improve live birth rates in women with habitual abortion.
Area of Science:
- Reproductive Medicine
- Obstetrics and Gynecology
- Genetics
Background:
- Habitual abortion, or recurrent pregnancy loss, presents significant challenges in reproductive medicine.
- The incidence of pregnancy wastage increases with subsequent pregnancies, necessitating effective diagnostic and therapeutic strategies.
Purpose of the Study:
- To analyze the pathogenesis of repeated spontaneous abortions in over 1,000 women over five years.
- To evaluate the efficacy of different treatment approaches for habitual abortion.
Main Methods:
- Diagnosis of congenital uterine abnormalities and surgical correction (metroplasty).
- Screening for antiphospholipid syndrome using anticardiolipin antibody (ACA) and lupus anticoagulant (LA) tests.
- Genetic analysis of partners for chromosomal abnormalities.
- Immunotherapy using husbands' lymphocytes for female partners.
Main Results:
- Metroplasty resulted in an 82% success rate for subsequent pregnancies in women with uterine abnormalities, compared to >98% prior loss.
- Antiphospholipid syndrome was diagnosed and successfully managed with appropriate medications.
- In couples with chromosomal abnormalities in the male partner, a high incidence of spontaneous abortion was observed.
- Immunotherapy led to successful pregnancies in 147 out of 311 treated women (47.3% success rate).
Conclusions:
- Early and comprehensive diagnosis is crucial for effective treatment of habitual abortion.
- Surgical, medical, and immunotherapeutic interventions can significantly improve pregnancy outcomes.
- Addressing underlying causes like uterine abnormalities, antiphospholipid syndrome, and genetic factors is key to managing recurrent pregnancy loss.